- General Drug Summary
- Description
- A potent anti-arrhythmia agent, effective in a wide range of ventricular and atrial arrhythmias and tachycardias. Paradoxically, however, in myocardial infarct patients with either symptomatic or asymptomatic arrhythmia, flecainide exacerbates the arrhythmia and is not recommended for use in these patients. [PubChem]
- Also Known As
- Flecainida [INN-Spanish]; Flecainidum [INN-Latin]
- Categories
- Anti-Arrhythmia Agen
- Structure
- Summary In Neonatal Jaundice
-
1 record(s) for Flecainide Adverse Event in Neonatal Jaundice.
- PMID
- Drug Name
- Efficacy
- Evidence
- 7776114
- Flecainide
- Adverse Event
- Clinical Trial
- Summary
- In utero exposure to flecainide acetate resulted in conjugated hyperbilirubinemia in this infant.
- Conjugated hyperbilirubinemia in a newborn infant after maternal (transplacental) treatment with flecainide acetate for fetal tachycardia and fetal hydrops. The Journal of pediatrics, 1995 Jun [Go to PubMed]
- An infant with intrauterine supraventricular tachycardia and fetal hydrops, successfully treated with administration of flecainide acetate to the mother had conjugated hyperbilirubinemia shortly after birth. An extensive evaluation failed to disclose a known cause. We believe that in utero exposure to flecainide acetate resulted in conjugated hyperbilirubinemia in this infant.